Nf2Tx
Cambridge, US · 1 known investors
NF2 Therapeutics (NF2Tx) is a biotech company developing therapies for neurofibromatosis 2 related schwannomatosis (NF2) and related disorders, including an antibody drug conjugate targeting meningiomas and an AAV-based gene therapy for vestibular schwannomas. It works with patients, physicians, and researchers to develop treatments for these rare genetic disorders.
BiotechHealthtech
Founders & leadership
MW
Michael WoottonCo-Founder & CEO
MD
Mark de SouzaCo-Founder
SP
Scott PlotkinCo-Founder
Board
MG
Marco Giovannini
Investors · 1
Frequently asked questions
- What does Nf2Tx do?
- NF2 Therapeutics (NF2Tx) is a biotech company developing therapies for neurofibromatosis 2 related schwannomatosis (NF2) and related disorders, including an antibody drug conjugate targeting meningiomas and an AAV-based gene therapy for vestibular schwannomas. It works with patients, physicians, and researchers to develop treatments for these rare genetic disorders.
- Who founded Nf2Tx?
- Nf2Tx was founded by Michael Wootton, Mark de Souza, Scott Plotkin.
- Who are Nf2Tx's investors?
- Nf2Tx's investors include Beacon Angels.
- Where is Nf2Tx headquartered?
- Nf2Tx is headquartered in Cambridge, US.